University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

B

Status	Drug name	NICE TAs	Comments
	Bosutinib	TA311 - Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation
	Botox A	TA260 - Botulinum toxin type A for the prevention of headaches in adults with chronic migraine
	Botulinum A toxin injection		Botox, Dysport and Xeomin. However Xeomin to be used first line for its licensed indications
	Botulinum toxin type A
	Botulinum toxin type A (Botox)		For hyperhidrosis
	Botulism antitoxin
	Brentuximab injection	TA446 - Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma TA478 - Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma TA577 - Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma TA641 - Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma	National CDF list. For hospital use only.
	Brentuximab vedotin (Adcetris®)	NICE TA 1059 Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma
	Brevinor		Umbrella service only
	Brexucabtagene autoleucel	TA893 - Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over

Building healthier lives